Variant report
Variant | nsv979607 |
---|---|
Chromosome Location | chr22:23262334-23266166 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:27)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:27 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr22:23262737-23263489 | K562 | blood: | n/a | n/a |
2 | BACH1 | chr22:23265361-23265362 | K562 | blood: | n/a | n/a |
3 | BHLHE40 | chr22:23263078-23263135 | K562 | blood: | n/a | n/a |
4 | CTCF | chr22:23264758-23264806 | GM10266 | blood: | n/a | n/a |
5 | EBF1 | chr22:23265150-23265460 | GM12878 | blood: | n/a | chr22:23265253-23265262 |
6 | MAZ | chr22:23263569-23263570 | K562 | blood: | n/a | n/a |
7 | PAX5 | chr22:23264598-23265353 | GM12878 | blood: | n/a | n/a |
8 | PAX5 | chr22:23264637-23265165 | GM12878 | blood: | n/a | n/a |
9 | PAX5 | chr22:23264872-23265139 | GM12878 | blood: | n/a | n/a |
10 | PAX5 | chr22:23264711-23265181 | GM12878 | blood: | n/a | n/a |
11 | POLR2A | chr22:23263405-23267833 | GM18526 | blood: | n/a | n/a |
12 | POLR2A | chr22:23264507-23265155 | GM12878 | blood: | n/a | n/a |
13 | POLR2A | chr22:23264596-23265085 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr22:23264605-23265108 | GM12878 | blood: | n/a | n/a |
15 | POLR2A | chr22:23264657-23265091 | GM12878 | blood: | n/a | n/a |
16 | POLR2A | chr22:23265930-23266400 | K562 | blood: | n/a | n/a |
17 | POU2F2 | chr22:23264564-23265035 | GM12878 | blood: | n/a | n/a |
18 | POU2F2 | chr22:23264653-23264916 | GM12878 | blood: | n/a | n/a |
19 | SP2 | chr22:23263671-23264669 | K562 | blood: | n/a | n/a |
20 | SPI1 | chr22:23264653-23265083 | K562 | blood: | n/a | n/a |
21 | SPI1 | chr22:23265658-23266027 | K562 | blood: | n/a | n/a |
22 | TCF3 | chr22:23264565-23264958 | GM12878 | blood: | n/a | n/a |
23 | UBTF | chr22:23265831-23265924 | K562 | blood: | n/a | n/a |
24 | UBTF | chr22:23263646-23263765 | K562 | blood: | n/a | n/a |
25 | UBTF | chr22:23262351-23262516 | K562 | blood: | n/a | n/a |
26 | USF2 | chr22:23262391-23262396 | K562 | blood: | n/a | n/a |
27 | WRNIP1 | chr22:23265939-23266137 | GM12878 | blood: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:23157854..23159575-chr22:23265576..23269716,3 | K562 | blood: | |
2 | chr22:23249460..23256264-chr22:23263399..23267410,8 | K562 | blood: | |
3 | chr22:23248970..23251030-chr22:23266059..23268328,2 | K562 | blood: | |
4 | chr22:23261117..23263641-chr22:23264707..23267231,3 | K562 | blood: | |
5 | chr22:23261117..23263641-chr22:23264707..23267231,3 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RTDR1-4 | chr22:23264861-23264965 | NONHSAT083834 |
2 | lnc-RTDR1-4 | chr22:23264978-23265153 | NONHSAT083834 |
No data |
No data |
Variant related genes | Relation type |
---|---|
IGLC7 | TF binding region |
IGLJ7 | TF binding region |
ENSG00000211684 | chromatin interactions |
ENSG00000254029 | chromatin interactions |
ENSG00000211685 | chromatin interactions |
ENSG00000222037 | chromatin interactions |
ENSG00000211680 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534089423 | chr22:23262335-23262336 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs553734474 | chr22:23262350-23262351 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs11090195 | chr22:23262360-23262361 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs545783258 | chr22:23262411-23262412 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs562492101 | chr22:23262421-23262422 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs576187129 | chr22:23262425-23262426 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs541980979 | chr22:23262429-23262430 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs59302672 | chr22:23262443-23262444 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs150655997 | chr22:23262454-23262455 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs116026811 | chr22:23262468-23262469 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs116325822 | chr22:23262529-23262530 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs532687641 | chr22:23262554-23262555 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs377643750 | chr22:23262585-23262586 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs552266767 | chr22:23262592-23262593 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs59871451 | chr22:23262645-23262646 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs568945203 | chr22:23262660-23262661 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs376502095 | chr22:23262682-23262683 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs139906533 | chr22:23262711-23262712 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs116818993 | chr22:23262716-23262717 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs149846322 | chr22:23262734-23262735 | Enhancers Weak transcription Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs146889260 | chr22:23262777-23262778 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs140500871 | chr22:23262812-23262813 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs181139838 | chr22:23262842-23262843 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs183919146 | chr22:23262843-23262844 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs188203479 | chr22:23262867-23262868 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs144237487 | chr22:23262880-23262881 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs529097315 | chr22:23262897-23262898 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs569493923 | chr22:23262921-23262922 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs369288795 | chr22:23262959-23262960 | Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs182082307 | chr22:23263012-23263013 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
31 | rs146548414 | chr22:23263020-23263021 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
32 | rs149154318 | chr22:23263043-23263044 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
33 | rs370695911 | chr22:23263046-23263047 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
34 | rs67457865 | chr22:23263081-23263082 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
35 | rs3029227 | chr22:23263084-23263085 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
36 | rs397752735 | chr22:23263088-23263089 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
37 | rs572120959 | chr22:23263097-23263098 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
38 | rs143297624 | chr22:23263152-23263153 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs148026342 | chr22:23263161-23263162 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs532651903 | chr22:23263213-23263214 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs552489217 | chr22:23263218-23263219 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs562538256 | chr22:23263219-23263220 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs531550236 | chr22:23263230-23263231 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs8139354 | chr22:23263251-23263252 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs552683862 | chr22:23263266-23263267 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs575124455 | chr22:23263269-23263270 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs534204198 | chr22:23263278-23263279 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
48 | rs568428852 | chr22:23263290-23263291 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs373988844 | chr22:23263294-23263295 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs372891336 | chr22:23263392-23263393 | Weak transcription Enhancers Strong transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Schizophrenia | 17504246 | CNVD |
Digeorge syndrome | 18033723 | CNVD |
22q11 deletion syndrome | 17034021 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
22q11 deletion syndrome | 16829213 | CNVD |
Autism | 22067053 | CNVD |
Autism | 19218893 | CNVD |
Biliary cancer | 22067053 | CNVD |
Congenital heart defect | 21390462 | CNVD |
Digeorge syndrome | 16617304 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Obsessive-compulsive disorder | 22067053 | CNVD |
Psychosis | 22067053 | CNVD |
Schizophrenia | 19415332 | CNVD |
Schizophrenia | 20587603 | CNVD |
Shprintzen syndrome | 19443537 | CNVD |
absent pulmonary valve syndrome | 16795129 | CNVD |
language delay | 22067053 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
renal disease | 17924346 | CNVD |
Schizophrenia | 20433910 | CNVD |
22q11 deletion syndrome | 17028864 | CNVD |
Schizophrenia | 16969581 | CNVD |
Non-syndromic sensorineural hearing loss | 17135275 | CNVD |
velo-cardio-facial syndrome | 17135275 | CNVD |
Digeorge syndrome | 18787571 | CNVD |
Autism | 18925931 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
22q11.2 microdeletion syndrome | 21547621 | CNVD |
Congenital heart defect | 21308838 | CNVD |
Digeorge syndrome | 16512914 | CNVD |
Digeorge syndrome | 20954168 | CNVD |
Nuchal translucency | 21837766 | CNVD |
Right aortic arch in the fetus | 17066500 | CNVD |
Shprintzen syndrome | 17117043 | CNVD |
Tetralogy of fallot | 17405110 | CNVD |
Velocardiofacial syndrome | 20140301 | CNVD |
Velocardiofacial syndrome | 16512914 | CNVD |
bone mass and metabolism | 20516202 | CNVD |
choanal atresia | 18209138 | CNVD |
extracardiac malformations | 17086578 | CNVD |
fetal heart defects | 21308838 | CNVD |
parathyroid gland dysfunction | 16793949 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
velopharyngeal insufficiency | 19620585 | CNVD |
Prader-willi syndrome | 20942916 | CNVD |
22q11 deletion syndrome | 17653112 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cat eye syndrome | 21549014 | CNVD |
Digeorge syndrome | 21549014 | CNVD |
22q11.2 microdeletion syndrome | 22051516 | CNVD |
22q11.2 microdeletion syndrome | 18483005 | CNVD |
22q11.2 microdeletion syndrome | 19565140 | CNVD |
22q11.2 microdeletion syndrome | 20396437 | CNVD |
22q11.2 microdeletion syndrome | 21390462 | CNVD |
22q11.2 microdeletion syndrome | 21573985 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 20970697 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Congenital heart defect | 21257016 | CNVD |
Developmental delay | 18414209 | CNVD |
DiGeorge-Velo cardiofacial | 19284877 | CNVD |
Epilepsy | 20970697 | CNVD |
Heart disease | 20551144 | CNVD |
Hughes'' syndrome | 16595601 | CNVD |
Mental retardation | 18414209 | CNVD |
Okamoto syndrome | 19046188 | CNVD |
Primary immunodeficiency | 22566803 | CNVD |
Schizophrenia | 20877625 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Velocardiofacial syndrome | 17556857 | CNVD |
Velocardiofacial syndrome | 20206275 | CNVD |
Velocardiofacial syndrome | 20970697 | CNVD |
delayed speech development | 21274400 | CNVD |
velo-cardio-facial syndrome | 16511839 | CNVD |
velo-cardio-facial syndrome | 21763005 | CNVD |
22q11.2 microdeletion syndrome | 18799940 | CNVD |
Digeorge syndrome | 20877625 | CNVD |
22q11.2 microdeletion syndrome | 18923514 | CNVD |
Congenital heart defect | 22185286 | CNVD |
DiGeorge-Velo cardiofacial | 16773131 | CNVD |
Digeorge syndrome | 20186050 | CNVD |
velo-cardio-facial conotruncal-face syndrome | 20186050 | CNVD |
22q11.2 microdeletion syndrome | 22116936 | CNVD |
Disorders of sex development | 22290220 | CNVD |
22q11.2 duplication syndrome | 18923514 | CNVD |
Autism | 22095694 | CNVD |
Mental retardation | 19951919 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Mental retardation | 16773131 | CNVD |
22q11.2 microdeletion syndrome | 22395003 | CNVD |
22q11.2 microdeletion syndrome | 18691436 | CNVD |
22q11.2 microdeletion syndrome | 18053182 | CNVD |
22q11.2 microdeletion syndrome | 18324686 | CNVD |
22q11.2 microdeletion syndrome | 20074913 | CNVD |
Congenital heart defect | 20802965 | CNVD |
Congenital heart defect | 21134246 | CNVD |
DiGeorge syndrome | 19040613 | CNVD |
DiGeorge-Velo cardiofacial | 18179902 | CNVD |
Digeorge syndrome | 18172682 | CNVD |
Digeorge syndrome | 22470819 | CNVD |
Digeorge syndrome | 21364285 | CNVD |
Neuroendocrine carcinoma | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20069674 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Tetralogy of fallot | 19144126 | CNVD |
Velo-cardio-facial syndrome | 21364285 | CNVD |
Velocardiofacial syndrome | 18788013 | CNVD |
cardiac malformation | 20573211 | CNVD |
cardiac malformation | 18172682 | CNVD |
velo-cardio-facial syndrome | 18636631 | CNVD |
Schizophrenia | 21822266 | CNVD |
synaptic plasticity | 21368174 | CNVD |
Schizophrenia | 18043741 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Autism | 19046189 | CNVD |
DiGeorge-Velo cardiofacial | 19047251 | CNVD |
Hypernasal speech | 21968682 | CNVD |
Mental retardation | 17339581 | CNVD |
diverse phenotype | 16760730 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
DiGeorge-Velo cardiofacial | 17597781 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Schizophrenia | 18806272 | CNVD |
Schizophrenia | 18990708 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Schizophrenia | 20075378 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Emphysema | 19352772 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Disease | 21346257 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 21147756 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Asthma | 21956041 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
22q11.23 microdeletion syndrome | 19193630 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Autism | 20841430 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ependymoma | 20639864 | CNVD |
Schizophrenia | 17989066 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:23249800-23270800 | Strong transcription | Right Atrium | heart |
2 | chr22:23254000-23268800 | Weak transcription | Spleen | Spleen |
3 | chr22:23257200-23268000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
4 | chr22:23257800-23264200 | Weak transcription | GM12878-XiMat | blood |
5 | chr22:23259400-23290200 | Enhancers | Primary B cells from peripheral blood | blood |
6 | chr22:23261800-23263000 | Enhancers | Primary B cells from cord blood | blood |
7 | chr22:23263000-23263600 | Weak transcription | Primary B cells from cord blood | blood |
8 | chr22:23263600-23289400 | Enhancers | Primary B cells from cord blood | blood |
9 | chr22:23264200-23264400 | Enhancers | GM12878-XiMat | blood |
10 | chr22:23264400-23265200 | Weak transcription | GM12878-XiMat | blood |
11 | chr22:23265200-23267400 | Enhancers | GM12878-XiMat | blood |
12 | chr22:23265800-23267000 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
13 | chr22:23266000-23266600 | Enhancers | Fetal Intestine Small | intestine |
14 | chr22:23266000-23266800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
15 | chr22:23266000-23269200 | Enhancers | Fetal Intestine Large | intestine |
16 | chr22:23266000-23269800 | Enhancers | Monocytes-CD14+_RO01746 | blood |